Skip to main content

Table 1 Characteristics of Study Participants

From: Latent profile analysis of cognitive decline and depressive symptoms after intracerebral hemorrhage

Variable No. %
No. of Individuals 784 100
Demographics   
Age at Enrollment (Mean, SD) 70.9 (12.8)
Sex (Male) 408 52
Race / Ethnicity 0  
- White 659 84
- Hispanic 55 7
- Black 47 6
- Other 23 3
Education (≥12 years) 463 59
Medical History   
Hypertension 596 76
Diabetes 157 20
Pre-ICH Depression 133 17
Coronary Artery Disease 118 15
Atrial Fibrillation 118 15
Previous Functional Dependence 71 9
Prior Ischemic Stroke / TIA 63 8
Prior ICH 24 3
Acute ICH Hospitalization   
Admission GCS (median, IQR) 14 (9–15)
Discharge mRS (median, IQR) 4 (3–5)
CT Imaging Data 0  
ICH Location 0  
- Lobar 416 53
- Non-lobar 353 45
- Mixed locations 15 2
ICH Volume (cc, median and IQR) 18.5 (6.1–29.8)
Intraventricular Extension 204 26
MRI Data   
ICH Etiological Classification   
- CAA-related ICH 400 51
- Mixed ICH 196 25
- HTNA-related ICH 188 24
Global CSVD Score (median, IQR) 2 (1–3)
Genetic Data   
APOE ε4 (≥ 1 copy) 165 21
APOE ε2 (≥ 1 copy) 110 14
Variable No. %
No. of Individuals 784 100
Medication Use after ICH   
Statins 274 35
SSRI 172 22
Antiplatelet Agents 125 16
Oral Anticoagulants 78 10
  1. All values presented as number and percentage, unless otherwise specified
  2. Abbreviations: CAA Cerebral Amyloid Angiopathy, CSVD Cerebral Small Vessel Disease, GCS Glasgow Coma Scale, HTNA Hypertensive Arteriopathy, ICH Intracerebral Hemorrhage, IQR Inter-quartile Range, mRS modified Rankin Scale, SD Standard Deviation, SSRI Selective Serotonin Reuptake Inhibitor